Short Term and Long-Term Efficacy of Calcipotriene/ Betamethasone Dipropionate Foam Combination
Ahmad Jalili,1 Anthony Bewley,2 Michael Sticherling,3 Linda Stein Gold4 1Dermatology & Skin Care Clinic, Buochs, Switzerland; 2Barts Health NHS Trust and Queen Mary University London, London, UK; 3Department of Dermatology, Psoriasis Center, University Medical Center, Erlangen, Germany; 4Departm...
Saved in:
Main Authors: | Jalili A (Author), Bewley A (Author), Sticherling M (Author), Stein Gold L (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Adjunctive Use of Calcipotriene/Betamethasone Dipropionate Foam in a Real-World Setting Curtails the Cost of Biologics Without Reducing Efficacy in Psoriasis
by: Jerry Bagel, et al.
Published: (2020) -
Calcipotriene/betamethasone dipropionate for the treatment of psoriasis vulgaris: an evidence-based review
by: Patel NU, et al.
Published: (2017) -
Fixed-dose combination of calcipotriene/betamethasone dipropionate foam for the management of mild-to-moderate psoriasis in daily clinical practice: a collection of clinical experiences
by: Anna Campanati, et al.
Published: (2024) -
Calcipotriol/betamethasone dipropionate aerosol foam for the treatment of psoriasis vulgaris: case series and review of the literature
by: Pinter A, et al.
Published: (2018) -
Plaque-Type Psoriasis Treated with Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam: A Prospective Study on Clinical and Dermoscopic Predictor Factors in Response Achievement and Retention
by: Enzo Errichetti, et al.
Published: (2020)